aminoglutethimide has been researched along with Overweight in 1 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.
| Excerpt | Relevance | Reference |
|---|---|---|
| "ABCSG-06 investigated the efficacy of tamoxifen vs tamoxifen plus aminoglutethimide in postmenopausal women with hormone receptor-positive breast cancer." | 9.17 | Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial. ( Balic, M; Dubsky, P; Fesl, C; Fitzal, F; Gnant, M; Greil, R; Hofbauer, F; Jakesz, R; Kwasny, W; Mlineritsch, B; Moik, M; Pfeiler, G; Ploner, F; Renner, K; Samonigg, H; Sandbichler, P; Seifert, M; Selim, U; Singer, C; Steger, GG; Stöger, H, 2013) |
| "ABCSG-06 investigated the efficacy of tamoxifen vs tamoxifen plus aminoglutethimide in postmenopausal women with hormone receptor-positive breast cancer." | 5.17 | Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial. ( Balic, M; Dubsky, P; Fesl, C; Fitzal, F; Gnant, M; Greil, R; Hofbauer, F; Jakesz, R; Kwasny, W; Mlineritsch, B; Moik, M; Pfeiler, G; Ploner, F; Renner, K; Samonigg, H; Sandbichler, P; Seifert, M; Selim, U; Singer, C; Steger, GG; Stöger, H, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pfeiler, G | 1 |
| Stöger, H | 1 |
| Dubsky, P | 1 |
| Mlineritsch, B | 1 |
| Singer, C | 1 |
| Balic, M | 1 |
| Fitzal, F | 1 |
| Moik, M | 1 |
| Kwasny, W | 1 |
| Selim, U | 1 |
| Renner, K | 1 |
| Ploner, F | 1 |
| Steger, GG | 1 |
| Seifert, M | 1 |
| Hofbauer, F | 1 |
| Sandbichler, P | 1 |
| Samonigg, H | 1 |
| Jakesz, R | 1 |
| Greil, R | 1 |
| Fesl, C | 1 |
| Gnant, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Phase III Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal, Hormone Receptor-positive Patients[NCT00309491] | Phase 3 | 2,021 participants (Actual) | Interventional | 1990-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for aminoglutethimide and Overweight
| Article | Year |
|---|---|
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined | 2013 |